Cite
HARVARD Citation
Invernizzi, F. et al. (n.d.). Safety and effectiveness of Regorafenib in recurrent HCC after liver transplantation and progression on Sorafenib: a real-life multicentre study. Digestive and liver disease. pp. e12-. [Online].